I-Corps: Thermostable liquid formulations of mRNAs and mRNA lipid nano-particles pharmaceu — NSF Award to University of North Caro
The broader impact/commercial potential of this I-Corps project is the development of an RNA formulation technology for safe storage and transport. The ability to transport and store mRNA-based pharmaceuticals without ultra-cold requirements may significantly lower the costs of distribution of mRNA drugs and vaccines.
| Award title | I-Corps: Thermostable liquid formulations of mRNAs and mRNA lipid nano-particles pharmaceu |
|---|---|
| Award ID | 2221899 |
| Awardee | University of North Carolina at Wilmington |
| City | WILMINGTON |
| State | NC |
| Amount obligated | $50,000 |
| Principal investigator | Ying Wang |
| Program | I-Corps |
| Start date | 05/01/2022 |
| Abstract | The broader impact/commercial potential of this I-Corps project is the development of an RNA formulation technology for safe storage and transport. The ability to transport and store mRNA-based pharmaceuticals without ultra-cold requirements may significantly lower the costs of distribution of mRNA drugs and vaccines. Also, elimination of the requirements for ultra-freezer and lyophilization will greatly increase the capacity and speed of deployment of mRNA pharmaceuticals as well as their acces |
| Source | NSF Awards |
$799/mo
Try NSFGrants →